1
Pont, LG, Sturkenboom, MCJM, van Gilst, WH, Denig, P, Haaijer-Ruskamp, FM
Veröffentlicht in: Pont , LG , Sturkenboom , MCJM , van Gilst , WH , Denig , P & Haaijer-Ruskamp , FM 2003 , ' Trends in prescribing for heart failure in Dutch primary care from 1996 to 2000 ' , Pharmacoepidemiology and Drug Safety , vol. 12 , no. 4 , pp. 327-334 . https://doi.org/10.1002/pds.809;
2003
Veröffentlicht in: Pont , LG , Sturkenboom , MCJM , van Gilst , WH , Denig , P & Haaijer-Ruskamp , FM 2003 , ' Trends in prescribing for heart failure in Dutch primary care from 1996 to 2000 ' , Pharmacoepidemiology and Drug Safety , vol. 12 , no. 4 , pp. 327-334 . https://doi.org/10.1002/pds.809;
2003
2
Geert Byttebier, Luc Belmans, Myriam Alexander, Bo E. H. Saxberg, Bart De Spiegeleer, Anton De Spiegeleer, Nick Devreker, Jens T. Van Praet, Karolien Vanhove, Reinhilde Reybrouck, Evelien Wynendaele, David S. Fedson
Veröffentlicht in: Human Vaccines & Immunotherapeutics, Vol 17, Iss 9, Pp 2841-2850 (2021);
2021
Veröffentlicht in: Human Vaccines & Immunotherapeutics, Vol 17, Iss 9, Pp 2841-2850 (2021);
2021
3
Ramos, Isaac Corro, Versteegh, Matthijs M., de Boer, Rudolf A., Koenders, Jolanda M. A., Linssen, Gerard C. M., Meeder, Joan G., Rutten-van Molken, Maureen P. M. H.
Veröffentlicht in: Ramos , I C , Versteegh , M M , de Boer , R A , Koenders , J M A , Linssen , G C M , Meeder , J G & Rutten-van Molken , M P M H 2017 , ' Cost Effectiveness of the Angiotensin Receptor Neprilysin Inhibitor Sacubitril/Valsartan for Patients with Chronic Heart Failure and Reduced Ejection Fraction in the Netherlands : A Country Adaptation Analysis Under the Former and Current Dutch Pharmacoeconomic Guidelines ' , Value in Health , vol. 20 , no. 10 , pp. 1260-1269 . https://doi.org/10.1016/j.jval.2017.05.013;
2017
Veröffentlicht in: Ramos , I C , Versteegh , M M , de Boer , R A , Koenders , J M A , Linssen , G C M , Meeder , J G & Rutten-van Molken , M P M H 2017 , ' Cost Effectiveness of the Angiotensin Receptor Neprilysin Inhibitor Sacubitril/Valsartan for Patients with Chronic Heart Failure and Reduced Ejection Fraction in the Netherlands : A Country Adaptation Analysis Under the Former and Current Dutch Pharmacoeconomic Guidelines ' , Value in Health , vol. 20 , no. 10 , pp. 1260-1269 . https://doi.org/10.1016/j.jval.2017.05.013;
2017